BioHeparin

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameBioHeparin
Drug Alias NameBALP technology heparin (BioTie)low-molecular weight heparin (BioTie)biologically active linear polysaccharide (BioTie)neoheparin1st-generation BALP (BioTie) +[7] 
ClassificationSmall molecules > Carbohydrate > Oligosaccharide
Mechanisms of ActionFactor IIa inhibitorsFactor Xa inhibitorsHeparin agonists
TargetsHeparinCoagulation factor XProthrombin
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyFinlandJapan
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiotie Therapies Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiotie Therapies CorpAjinomoto Medica Co LtdInalco SpA
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A